daunorubicin has been researched along with Desmoplastic Small Cell Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Algar, E; Ashley, DM; Bandopadhayay, P; Ekert, PG; Gordon, L; Jabbour, AM; Popovski, D; Riffkin, C; Rigby, L; Salmanidis, M; Thomas, DM; Watkins, DN | 1 |
1 other study(ies) available for daunorubicin and Desmoplastic Small Cell Tumor
Article | Year |
---|---|
The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblasts.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Cells, Cultured; Daunorubicin; Desmoplastic Small Round Cell Tumor; DNA Copy Number Variations; Drug Resistance, Neoplasm; Fibroblasts; Humans; Mice; Mice, Transgenic; Nuclear Proteins; Oncogene Proteins, Fusion; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Radiation Tolerance; Transcriptome; Tumor Suppressor Protein p53; Wnt Signaling Pathway | 2013 |